In addition, it authorizes this booster dose for people between the ages of 12 and 16 who belong to risk groups.
The Swiss health authorities, which a month ago gave the green light to a third dose of anticovid vaccine for people over 65 years of age and other risk groups, have today extended this authorization to the entire population over 16 years of age.
The authorization by Swissmedic, the regulatory body for the pharmaceutical sector in Switzerland, currently refers only to the vaccine Pfizer/BioNTech, despite the fact that in the Central European country doses of those developed by Moderna and Janssen have also been administered.
Swissmedic has also indicated in its official statement that people over 12 years of age belonging to risk groups (for example, immunosuppressed people) may also receive the third authorized dose.
The decision comes at a time when Switzerland, like other countries in the area, is experiencing a noticeable increase in the number of cases, although their relative data are still far from those of neighboring countries such as Germany or Austria.
On the other hand, the measure is announced despite the fact that the World Health Organization (WHO) has requested a moratorium on booster doses to countries where the vaccination rate is high, in order to improve the distribution of doses in developing nations with low levels of protection against covid-19.
Kingston is an accomplished author and journalist, known for his in-depth and engaging writing on sports. He currently works as a writer at 247 News Agency, where he has established himself as a respected voice in the sports industry.
